Paper Details

  1. Home
  2. Paper Details

A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route).

Author: FaddaG, NicolettiG, SchitoG C, SerraA

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This randomized trial compared thiamphenicol glycinate acetylcisteinate (TGA) with other standard antibiotics for upper respiratory tract infections. TGA was effective in treating both severe and mild symptoms, with good tolerability and no significant adverse events.
Paper Details　
Original Abstract of the Article :
Eight hundred and seventeen patients with upper respiratory tract infections were treated with thiamphenicol glycinate acetylcisteinate (TGA) or other standard antibiotics for 6-10 days in a randomised trial. In 419 out of 817 patients, the symptomatology was severe and they were treated with TGA in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/039463200702000319

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Upper Respiratory Tract Infections: A New Therapeutic Approach

Upper respiratory tract infections (URTIs) are a common affliction, and finding the right treatment can be like navigating a vast desert of options. This study delves into the effectiveness of thiamphenicol glycinate acetylcisteinate (TGA) in sequential therapy for URTIs. The authors conducted a randomized trial comparing the efficacy of TGA with other standard antibiotics, demonstrating its effectiveness in reducing symptoms and achieving microbiological eradication.

A Promising Oasis: TGA Shows Effectiveness in Combating URTIs

This research highlights the potential of TGA as a valuable tool for combating URTIs. The study's findings demonstrate its effectiveness in reducing symptoms and eradicating pathogens, suggesting a promising option for a wide range of URTI patients.

Improving Patient Outcomes: TGA's Potential Benefits

This study points to the potential for TGA to enhance the management of URTIs, offering a promising approach for improving patient outcomes and reducing the discomfort associated with these common infections.

Dr. Camel's Conclusion

This research offers a comprehensive evaluation of thiamphenicol glycinate acetylcisteinate (TGA) in the treatment of upper respiratory tract infections. The study's findings demonstrate its effectiveness in reducing symptoms and achieving microbiological eradication, highlighting its potential as a valuable addition to the therapeutic arsenal for managing these common infections.

Date :
  1. Date Completed 2007-11-29
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

17880774

DOI: Digital Object Identifier

10.1177/039463200702000319

Related Literature

Article Analysis
・Effects of acetylcysteine oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.